Skip to Main Content

Paper Details

Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue Disease.
Open Forum Infect Dis
3
2021
Connective Tissue Disease, Patient, SARS-CoV-2, T-cell, acute respiratory syndrome, connective tissue disease, coronavirus 2, coronavirus 2 receptor binding domain, coronavirus disease, mRNA, patient
Author NameAffiliation
Kara L LynchUniversity of California San Francisco
Steven G DeeksUniversity of California San Francisco
Steven G DeeksUniversity of California San Francisco
Timothy J HenrichUniversity of California San Francisco
  • 1 - 4

Datasets

Release 1.2